Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. - Wikidata - awgldk - TriplyDB

Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance.

Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance.

http://www.wikidata.org/entity/Q33943545

about

Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis.Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis.Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB.Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy.Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia.Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis.Changes in serum cytokine levels in active tuberculosis with treatment.Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosis Elevated HMGB1-related interleukin-6 is associated with dynamic responses of monocytes in patients with active pulmonary tuberculosis.Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis Associations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study.HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.Immune responses to tuberculosis in developing countries: implications for new vaccines.Chemokines shape the immune responses to tuberculosis.Mycobacterium tuberculosis exploits human interferon γ to stimulate macrophage extracellular trap formation and necrosis.A study of serum malondialdehyde and cytokine in tuberculosis patients.Immunoregulation in TB: observations and implications Mycobacterium bovis bacilli Calmette-Guerin regulates leukocyte recruitment by modulating alveolar inflammatory responses.Tuberculosis State Is Associated with Expression of Toll-Like Receptor 2 in Sputum Macrophages.Protective responses in tuberculosis: induction of genes for interferon-gamma and cytotoxicity by Mycobacterium tuberculosis and during human tuberculosis.

P2860

Q24816509-F7590936-C592-4589-AE2A-8A39BE1AEB8D Q28387743-47EB1C61-2B64-4592-8862-9E0CA0BD97FE Q28396491-663748FD-15EF-40F7-9743-D30CB3FBDF4F Q28729980-3A136115-C50C-411F-83A5-B1F8EE060FC5 Q28742421-54D3B1D2-F7F0-4D46-B772-AF9743AF3FBC Q30525291-8D19DCD3-951B-4AB6-971C-4E8CA4DBDDB6 Q33294505-5416BB08-7A4F-47A3-9C30-2E2A9F9CEB16 Q33577389-3C7442DB-89EA-4D12-B468-1E9EA813FE9D Q33595443-366810E5-F3E2-4A7C-A475-37CE6B5886E4 Q33614197-C1AAE0B9-252D-4F22-8C72-B8ED63A30929 Q33825672-7BA54C71-9E20-4E06-9CB9-4A273083A33F Q33867418-5C72817A-9BDF-4019-9B71-EC0322CE5D37 Q34203521-30A29D05-BD55-4A27-AD16-E9CDD27A6D25 Q34945307-EA05B0D7-CE6A-478E-A53B-9350F307F27A Q35138740-A1DA290A-D526-4E29-AC0C-F1CD554D86A9 Q35406168-93D807B6-042D-4542-A663-327B429BFCE3 Q35609246-7589FDFC-36A7-469B-971D-9ECEEC2BBFFA Q36096192-ED0D62F1-3571-443D-94BF-0F1B4D3D836A Q36109585-870BC344-9C9A-4F1B-8898-338CB096FA68 Q36213975-EBE3B0BB-DCB3-4F3D-8AE0-5E3D3CB3A7DA Q36640097-8C23A1DD-BCDC-412D-95F4-4CF3903B6C4A Q36882480-A2A45ECC-C966-48C5-869C-CECC9BB266A9 Q37350001-7D625B07-CE75-4840-96A7-E58C0086809E Q37742701-034E5404-3938-480B-B8B6-F47F10259C32 Q39447138-B0F998AB-5A0C-42C8-AC66-95EC20AC059E Q43957358-9B08E56F-E3B9-4641-8EE9-F7434143FBF3 Q45024305-6C935086-8D5A-4A3A-89D7-DFF4E5ED9164

P2860

Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance.

http://www.wikidata.org/entity/Q33943545

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Sputum cytokine levels in pati ...... rs of mycobacterial clearance.

@ast

Sputum cytokine levels in pati ...... rs of mycobacterial clearance.

@en

type

label

Sputum cytokine levels in pati ...... rs of mycobacterial clearance.

@ast

Sputum cytokine levels in pati ...... rs of mycobacterial clearance.

@en

prefLabel

Sputum cytokine levels in pati ...... rs of mycobacterial clearance.

@ast

Sputum cytokine levels in pati ...... rs of mycobacterial clearance.

@en

P1433

Q33943545-47B74EC4-EC06-4A6F-969C-982AE81A67CB

P1476

Q33943545-D0F14618-E754-468D-8A55-60C183967D11

P2093

Q33943545-069FBD38-B04A-44DC-8684-13F734B088CB

Q33943545-1EC26CEE-6B91-4119-A745-7C93D19A7A4F

Q33943545-21946CBB-8FB9-43B8-AD46-A4DEAEBC051E

Q33943545-32375F55-E10F-4B24-BFCD-E602A2479E44

Q33943545-35DB17AD-2FF3-40F2-AC96-B38CB3017EAC

Q33943545-44784866-507F-44DD-8623-DA5F304BB96C

Q33943545-48548447-1776-4A91-B36F-E0D7C8897DCD

Q33943545-4B744DA1-E376-46FC-BEEF-10022A251C00

Q33943545-7E967D37-C864-424A-ADB6-76F6F4F7C48E

Q33943545-81449985-CF3C-4970-B0D5-EFF2EA15D75D

P2860

Q33943545-15006AC0-9158-4B6F-8BBC-575E4827818A

Q33943545-2500406A-A05D-478C-9A71-2EE692873164

Q33943545-352FE890-306C-49D7-B2BA-06C6C6D03DF6

Q33943545-71290CE1-A86B-421B-A7D3-500480171602

Q33943545-8E053942-AC8B-4B42-A601-777DD0862030

Q33943545-973253AC-80D7-43FB-9606-A05AF7C49C96

Q33943545-A564BEF3-B505-4B5E-BEC3-71D163F83D64

Q33943545-AB4295D6-9434-451E-810F-61672CDF6CA5

Q33943545-B7A7748E-D981-439C-B83E-80B3ED5296FF

Q33943545-DD190623-75D2-4612-9648-01BCDC271A71

P304

Q33943545-5E0C5BE0-F92B-4F7B-99E5-C1E6598583C3

P31

Q33943545-1410F6BF-6880-4F0A-B7EF-9E596431B936

P356

Q33943545-5C4AC649-9897-432B-B66C-8EA3FF49C6CB

P433

Q33943545-DBC71488-4667-4140-8B29-2938AB281CAA

P478

Q33943545-AA4071C9-CEE3-4AC5-AFA9-02BB55A1BF8D

P50

Q33943545-07D7911C-244B-4C72-8397-30A1D3E66DFA

P577

Q33943545-6FBE4838-491D-4B17-BF85-4240AFF3CAB4

P698

Q33943545-B7D739C5-2AA9-4186-8BCC-0DE71EA2A366

P921

Q33943545-38CD21F1-2D94-46AC-95AA-AB20522AD06D

Q33943545-8B18E9B4-7F0D-4142-B4A3-514A06AD4624

P932

Q33943545-65FE87E2-D522-4481-9E6F-4F5A17B6E050

P356

CDLI.9.4.818-823.2002

P1433

Clinical and Vaccine Immunology

P1476

Sputum cytokine levels in pati ...... ers of mycobacterial clearance

@en

P2093

Christina S Hirsch

http://www.w3.org/2001/XMLSchema#string

Fabiola Ribeiro

http://www.w3.org/2001/XMLSchema#string

Fausto E Pereira Lima

http://www.w3.org/2001/XMLSchema#string

Jerrold J Ellner

http://www.w3.org/2001/XMLSchema#string

John L Johnson

http://www.w3.org/2001/XMLSchema#string

Moises Palaci

http://www.w3.org/2001/XMLSchema#string

Reynaldo Dietze

http://www.w3.org/2001/XMLSchema#string

Ricardo T Sá

http://www.w3.org/2001/XMLSchema#string

Rodrigo Ribeiro-Rodrigues

http://www.w3.org/2001/XMLSchema#string

Tatiana Resende Co

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice

Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

Disseminated tuberculosis in interferon gamma gene-disrupted mice

Neutrophil-derived proteins: selling cytokines by the pound.

Correlation of CD4:CD8 ratio and tumour necrosis factor (TNF)alpha levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis.

Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis.

Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease.

Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects.

Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy.

P304

818-823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CDLI.9.4.818-823.2002

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Ethel Leonor Noia Maciel

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12093679

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

120011

http://www.w3.org/2001/XMLSchema#string